Service Implementation of Military Personnel Antibody

MalaysiaTenders notice for Service Implementation of Military Personnel Antibody. The reference ID of the tender is 67520876 and it is closing on 15 Jun 2022.

100% Secure Payments

Tender Details

  • Country: Malaysia
  • Summary: Service Implementation of Military Personnel Antibody
  • MYT Ref No: 67520876
  • Deadline: 15 Jun 2022
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: QT220000000020737
  • Purchaser's Detail :
  • Purchaser : MARKAS ANGKATAN TENTERA MALAYSIA (ATM)
    Attn: Kapt Muhammad Najhan Bin Md Bohari Tel: +60-03-41454290
    Email :farmasi93depoh@yahoo.com

  • Description :
  • Quotation are invited for Service Implementation of Military Personnel Antibody Level before and after Dosage of the Covid Vaccine 19 Ministry: Kementerian Pertahanan Invitation Closing Date: 15/06/2022 Date of Invitation: 08/06/2022 [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
MalaysiaTenders Features

MalaysiaTenders Features

Fresh and verified Tenders from Malaysia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Malaysia in your email inbox.

  Chat with us